The Discounted Cash Flow (DCF) valuation of Infinity Pharmaceuticals Inc (INFI) is (57.43) USD. With the latest stock price at 0.04 USD, the upside of Infinity Pharmaceuticals Inc based on DCF is -128580.1%.

Is INFI a buy or a sell?

Based on the latest price of 0.04 USD and our DCF valuation, Infinity Pharmaceuticals Inc (INFI) is a sell. Selling INFI stocks now will result in a potential gain of 128580.1%.

Note: valuation result may not be accurate due to the company's negative earnings.

	Range	Selected
WACC / Discount Rate	5.2% - 6.4%	5.8%
Long-term Growth Rate	3.0% - 5.0%	4.0%
Fair Price	(407.85) - (31.67)	(57.43)
Upside	-912509.4% - -70942.0%	-128580.1%

0.04 USD

Stock Price

(57.43) USD

Fair Price

REVENUE & EXPENSES

CAPEX

D&A

WORKING CAPITAL

TERMINAL VALUE

INFI DCF Valuation: Revenue & Expenses Forecast

(USD in millions)		Projections

	12-2022	12-2023	12-2024	12-2025	12-2026	12-2027

Revenue	3	3	3	3	3	3
% Growth	40%	-2%	9%	5%	5%	10%

Cost of goods sold	(2)	(1)	(2)	(2)	(2)	(2)
% of Revenue	60%	57%	54%	52%	49%	47%

Selling, G&A expenses	(13)	(13)	(14)	(15)	(16)	(18)
% of Revenue	519%	519%	519%	519%	519%	519%

Research & Development	(32)	(32)	(35)	(36)	(38)	(42)
% of Revenue	1250%	1250%	1250%	1250%	1250%	1250%

Net interest & other expenses	0	0	1	1	1	1
% of Revenue	18%	18%	18%	18%	18%	18%

Tax expense	0	12	13	13	14	15
Tax rate	0%	27%	27%	27%	27%	27%

Net profit	(44)	(32)	(35)	(36)	(38)	(42)
% Margin	-1711%	-1247%	-1245%	-1243%	-1241%	-1239%